Annals on Call
In this episode of Annals On Call, Dr. Centor discusses the cost-effectiveness of sodium–glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes with Drs. Neda Laiteerapong and Aaron Winn.
First, listen to the podcast. After listening, ACP members can take the CME/MOC quiz for free.
